Skip to content
healthcare.dev

GaviLyte-H and Bisacodyl

NDC 43386-071, Polyethylene Glycol 3350, Sodium Chloride, Sodium Bicarbonate, Potassium Chloride and Bisacodyl Delayed-release Tablet, kit, from Lupin Pharmaceuticals, Inc..

Product NDC
43386-071
Status
Listed
Labeler
Lupin Pharmaceuticals, Inc.
Dosage form
KIT
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA202217
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/43386-071 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

None listed.

Package NDCNDC-11Package
43386-071-83433860071831 KIT in 1 KIT (43386-071-83) * 1 TABLET, DELAYED RELEASE in 1 BLISTER PACK (43386-010-61) * 2 L in 1 BOTTLE (43386-070-17)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/78fe1c29-e22a-4615-a2f9-a61cd4eb38a3

Use it

Look up 43386-071 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/43386-071 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 43386-071. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.